Kenneth Baum

Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America

Clinical Infectious Diseases · 2004 · 117 citations

Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group

Antiviral Therapy · 1999 · 113 citations